Cytomegalovirus (CMV) continues to be one of the most common infections after solid-organ
transplantation, resulting in significant morbidity, graft loss, and adverse outcomes …

Cytomegalovirus (CMV) infection is still a major complication after kidney transplantation.
Although cytotoxic CMV-specific T cells play a crucial role controlling CMV survival and …

Background. Quantification of cytomegalovirus (CMV) load is central to the management of
CMV infections in immunocompromised patients, but quantitative results currently differ …

Background. Cytomegalovirus (CMV) load measurement is used to assess the efficacy of
treatment of CMV disease, but lacks standardization. Using the World Health Organization …

BACKGROUND: Valganciclovir preemptive therapy guided by the viral load is the current
strategy recommended for preventing CMV disease in CMV-seropositive Solid Organ …

Introduction: Cytomegalovirus (CMV) infection is a common infectious complication after
solid organ transplantation (SOT) and is associated with the increased risk of opportunistic …

Background Cytomegalovirus (CMV) is a major pathogen affecting solid organ transplant
(SOT) recipients. Prophylactic strategies have decreased the rate of CMV infection/disease …

Applying molecular methods to the detection and quantification of cytomegalovirus (CMV)
DNA in transplant recipients has been much more challenging than expected. After 20 …

BACKGROUND: The use of T-cell-depleting antibody, such as thymoglobulin, is a risk factor
for cytomegalovirus (CMV) infection. We studied the effectiveness of 6 months of low-dose …

Background Cytomegalovirus (CMV) remains an important pathogen in transplant patients,
and valacyclovir (VACV) prophylaxis 8 g/day has been used in high-risk CMV …